Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Dec 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5155471014 | Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5155472019 | Choline salicylate 87 mg/g oromucosal gel | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) | Is a | Product manufactured as oromucosal dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) | Is a | Choline salicylate only product | false | Inferred relationship | Some | ||
| Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) | Has manufactured dose form | Oromucosal gel | true | Inferred relationship | Some | ||
| Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Choline salicylate | true | Inferred relationship | Some | 1 | |
| Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Choline salicylate | true | Inferred relationship | Some | 1 | |
| Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) | This attribute specifies the numerator unit for the concentration strength of a product. | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) | This attribute specifies the denominator unit for the concentration strength of a product. | g | true | Inferred relationship | Some | 1 | |
| Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) | Is a | Product containing only choline salicylate in oromucosal dose form (medicinal product form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR